Speed-to-market is a top priority for pharmaceutical firms today. CDMOs are offering accelerated timelines by integrating development, formulation, and manufacturing into streamlined workflows—reducing delays and improving commercial readiness. https://www.marketresearchfuture.com/reports/cmo-cdmo-market-21874